Sector / Industry News › Sub-category
Pharma / Healthcare
22 articles
Department of Pharmaceuticals Hosts AI in Pharma Webinar
The Department of Pharmaceuticals organized a webinar on AI and emerging technologies in pharmaceuticals and regulations on 04 April 2026.
The webinar highlighted AI's role in drug discovery, developm
India's Minister and IDF Discuss Indigenous Insulin Production
Union Minister Dr. Jitendra Singh and IDF President-elect Dr. Niti Pall discussed scaling up indigenous production of biosimilar insulin and diabetes care devices.
The meeting highlighted global insul
Granules India's US Facility Completes FDA Audit with 4 Observations
Granules India's US subsidiary, Granules Pharmaceuticals, Inc., has completed a routine cGMP audit by the US FDA at its Chantilly facility.
The audit, conducted from March 30 to April 3, 2026, resulte
Kauvery Hospital Performs 3-Hour Dual Arrhythmia Ablation
Kauvery Hospital, Chennai successfully treated a 71-year-old patient with atrial fibrillation and ventricular tachycardia in a single 3-hour session.
The procedure combined cryoballoon ablation for AF
Firstsource Named Leader in 2026 Healthcare Payer Assessments
Firstsource Solutions named a Leader in Everest Group's Healthcare Payer Intelligent Operations PEAK Matrix® Assessment 2026, among 9 of 33 globally evaluated providers.
Firstsource also recognized as
Glenmark Takes Direct U.S. Control of RYALTRIS®
Glenmark Pharmaceuticals assumes end-to-end commercialization and distribution of RYALTRIS® in the U.S. effective April 1, 2026.
RYALTRIS® is Glenmark's first innovative product in the U.S., a fixed-d
AIIA's Ayurvedic Stress Management Reaches 35,704 Police Personnel
The All India Institute of Ayurveda's (AIIA) Public Health Initiative on stress management has reached 35,704 police personnel through 206 camps, screening 7,752 individuals and providing Ayurvedic tr
IndiaAI CATCH Funds 10 AI Cancer Solutions
The IndiaAI Mission, approved in March 2024, promotes AI solutions for societal challenges, with CATCH focusing on cancer care through AI innovation.
Under CATCH, 10 AI solutions for cancer care were
Nasha Mukt Bharat Abhiyan Reaches 25.99+ Crore, 8.2 Lakh Sought Treatment
Nasha Mukt Bharat Abhiyan (NMBA) extended to all districts, reaching 25.99+ crore people, including 9.39 crore youth and 6.40 crore women through 8.23+ lakh activities.
Treatment seekers increased by
Government Expands Mental Health Services via Tele-MANAS and NMHP
The government has implemented the National Mental Health Programme (NMHP) and District Mental Health Programme (DMHP) across 767 districts, providing outpatient services, assessment, and drugs.
Over
AGEasy Launches India's First Smart Diaper Pants
Antara Assisted Care Services (AACSL), wholly owned subsidiary of Max India Ltd, launched AGEasy Adult Diaper Pants with proprietary Smart Liquid Distribution™ technology.
The product is India's first
Lupin Gets FDA Tentative Approval for Sugammadex Injection
Lupin received tentative U.S. FDA approval for Sugammadex Injection (200 mg/2 mL and 500 mg/5 mL) ANDA on March 31, 2026.
The product is bioequivalent to Merck's Bridion® Injection, used for reversing
Corona Remedies Acquires Wokadine® from Dr. Reddy's
Corona Remedies acquires Wokadine® brand from Dr. Reddy's Laboratories, marking its fifth inorganic acquisition, effective March 30, 2026.
Wokadine® is ranked #2 in India's INR 648 Cr Povidone Iodine
Budget 2026-27 Boosts Healthcare Funding by 10%
The Union Budget 2026-27 increases the Ministry of Health and Family Welfare allocation by 10% to ₹1,06,530.42 crore, focusing on universal healthcare and infrastructure.
Key initiatives include a 100
Dr. Jitendra Singh Releases Obesity and CVD Textbook
Union Minister Dr. Jitendra Singh released a comprehensive cardiology textbook on obesity and lipid management, edited by Dr. H.K. Chopra.
The textbook, with 300+ contributors, shifts focus to precisi
Sun Pharma Philogen Fibromun Nidlegy Clinical Updates
Sun Pharma's partner Philogen reported that Fibromun's Phase II FLASH (STS) and GLIOSTAR (glioblastoma) trials both failed to meet their primary endpoints.
Nidlegy's Phase II Duncan study showed 52.6%
Alembic Pharma Gets USFDA Approval Paroxetine ER Tablets
Alembic Pharmaceuticals received USFDA final approval for Paroxetine Extended-Release Tablets USP, 12.5 mg on 27th March 2026.
The approved sANDA is therapeutically equivalent to Paxil CR Tablets 12.5
Sanofi Consumer Healthcare India First Investor Meet
Sanofi Consumer Healthcare India Limited (SCHIL) held its first Institutional Investor Meet on 24th March 2026, filed under Regulation 30 of SEBI LODR.
Company reported ₹880 crore turnover, ~37% Profi
Antara Noida Care Home Gets NABH Accreditation
Antara's Noida Sector 66 care home becomes the first senior care facility in Noida district to receive NABH Care Home Accreditation.
This is the second NABH-accredited facility in Antara's network, ma
Wanbury Launches Pediatric Coriminic CPM, NS Drops
Wanbury Limited launched Coriminic CPM Drops (Chlorpheniramine Maleate) and Coriminic NS Nasal Drops for children under 4 years.
The launches address DCGI restrictions on fixed-dose combinations (Chlo
Lupin Gets Tentative FDA Approval for Pitolisant Tablets
Lupin received tentative U.S. FDA approval for its ANDA for Pitolisant Tablets in 4.45mg and 17.8mg strengths.
The product is bioequivalent to Wakix® and will be manufactured at Lupin's Nagpur facilit
TAKE Solutions Launches AI Health Platform Take.Health
TAKE Solutions launched Take.Health, an AI-driven digital health companion targeting India's USD 197 billion preventive healthcare market by 2030.
The platform offers AI-powered lab report analysis, p